Cargando…
Eradication of common pathogens at days 2, 3 and 4 of moxifloxacin therapy in patients with acute bacterial sinusitis
BACKGROUND: Acute bacterial sinusitis (ABS) is a common infection in clinical practice. Data on time to bacteriologic eradication after antimicrobial therapy are lacking for most agents, but are necessary in order to optimize therapy. This was a prospective, single-arm, open-label, multicenter study...
Autores principales: | Ariza, Horacio, Rojas, Ramon, Johnson, Peter, Gower, Richard, Benson, Alice, Herrington, Janet, Perroncel, Renee, Pertel, Peter |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1508156/ https://www.ncbi.nlm.nih.gov/pubmed/16646958 http://dx.doi.org/10.1186/1472-6815-6-8 |
Ejemplares similares
-
Antimicrobial resistance of H. pylori to the outcome of 10-days vs. 7-days Moxifloxacin based therapy for the eradication: a randomized controlled trial
por: Bago, Josip, et al.
Publicado: (2010) -
Efficacy of 7-Day and 14-Day Bismuth-Containing Quadruple Therapy and 7-Day and 14-Day Moxifloxacin-Based Triple Therapy as Second-Line Eradication for Helicobacter pylori Infection
por: Lee, Seong tae, et al.
Publicado: (2015) -
Moxifloxacin and bilateral acute iris transillumination
por: Knape, Robert M, et al.
Publicado: (2013) -
Effectiveness of 7-Day and 14-Day Moxifloxacin-Dexlansoprazole Based Triple Therapy and Probiotic Supplement for Helicobacter Pylori Eradication in Thai Patients with Non-Ulcer Dyspepsia: A Double-Blind Randomized Placebo-Controlled Study
por: Chotivitayatarakorn, Peranart, et al.
Publicado: (2017) -
Moxifloxacin-warfarin interaction
por: Ji, Yan, et al.
Publicado: (2012)